Indian Immunologicals (IIL), a vaccine manufacturing facility, has announced the groundbreaking of a new Sterile Filling Facility (SFF) at its manufacturing plant in Phase-III of Genome Valley in Karkapatla, Ranga Reddy district of Telangana.

The company will make an investment to the tune of Rs 75 crore towards the upcoming filling facility. The company will increase capacity to supply lifesaving vaccines such as the Anti Rabies Vaccine (ARV) -- Abhayrab.

The sterile facility is equipped with hi-end filling equipment and expected to be ready by 2020.

With supply from this facility, the company will continue to be the largest rabies vaccine manufacturer in the country.

The company has four manufacturing facilities at various locations. Karkapatla, Telangana -- human vaccines and animal health formulations; Ooty, Tamil Nadu -- anti-rabies production unit; Hyderabad, Telangana – human biologicals unit (Gachibowli) and animal vaccines unit; Dargaville, New Zealand -- New Bovine Serum.